Mathew Robson
Overview
Explore the profile of Mathew Robson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
457
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ferrari M, Righi M, Baldan V, Wawrzyniecka P, Bulek A, Kinna A, et al.
Nat Commun
. 2024 Feb;
15(1):1583.
PMID: 38383515
Peripheral T cell lymphomas are typically aggressive with a poor prognosis. Unlike other hematologic malignancies, the lack of target antigens to discriminate healthy from malignant cells limits the efficacy of...
2.
Kokalaki E, Ma B, Ferrari M, Grothier T, Hazelton W, Manzoor S, et al.
Mol Ther
. 2023 Dec;
32(2):556-558.
PMID: 38103549
No abstract available.
3.
Taylor J, Bulek A, Gannon I, Robson M, Kokalaki E, Grothier T, et al.
Front Immunol
. 2023 Jun;
14:1119350.
PMID: 37334382
SHP1 and SHP2 are SH2 domain-containing proteins which have inhibitory phosphatase activity when recruited to phosphorylated ITIMs and ITSMs on inhibitory immune receptors. Consequently, SHP1 and SHP2 are key proteins...
4.
McKenzie C, El-Kholy M, Parekh F, Robson M, Lamb K, Allen C, et al.
Mol Ther Nucleic Acids
. 2023 May;
32:603-621.
PMID: 37200859
The hostile tumor microenvironment limits the efficacy of adoptive cell therapies. Activation of the Fas death receptor initiates apoptosis and disrupting these receptors could be key to increasing CAR T ...
5.
Kokalaki E, Ma B, Ferrari M, Grothier T, Hazelton W, Manzoor S, et al.
Mol Ther
. 2023 Mar;
31(7):2089-2104.
PMID: 36945773
CAR T cells recognizing CD19 effectively treat relapsed and refractory B-ALL and DLBCL. However, CD19 loss is a frequent cause of relapse. Simultaneously targeting a second antigen, CD22, may decrease...
6.
Megson D, Brown T, Jones G, Robson M, Johnson G, Tiktak G, et al.
Chemosphere
. 2021 Oct;
288(Pt 3):132639.
PMID: 34687677
Polychlorinated biphenyls (PCBs) can provide crucial information into the bioaccumulation and biomagnification of POPs in marine mammals. Muscle tissue samples were obtained for detailed PCB congener specific analysis of all...
7.
Carter T, Agliardi G, Lin F, Ellis M, Jones C, Robson M, et al.
Small
. 2021 Mar;
17(14):e2005241.
PMID: 33734595
Magnetic hyperthermia (MH) harnesses the heat-releasing properties of superparamagnetic iron oxide nanoparticles (SPIONs) and has potential to stimulate immune activation in the tumor microenvironment whilst sparing surrounding normal tissues. To...
8.
Marchetti C, Zyner K, Ohnmacht S, Robson M, Haider S, Morton J, et al.
J Med Chem
. 2018 Jan;
61(6):2500-2517.
PMID: 29356532
Human pancreatic ductal adenocarcinoma (PDAC) involves the dysregulation of multiple signaling pathways. A novel approach to the treatment of PDAC is described, involving the targeting of cancer genes in PDAC...
9.
Abdollah M, Carter T, Jones C, Kalber T, Rajkumar V, Tolner B, et al.
ACS Nano
. 2018 Jan;
12(2):1156-1169.
PMID: 29341587
The magnetic properties and safety of dextran-coated superparamagnetic iron oxide nanoparticles (SPIONs) have facilitated their clinical use as MRI contrast agents and stimulated research on applications for SPIONs in particle...
10.
Megson D, Reiner E, Jobst K, Dorman F, Robson M, Focant J
Anal Chim Acta
. 2016 Oct;
941:10-25.
PMID: 27692373
The field of environmental forensics emerged in the 1980s as a consequence of legislative frameworks enacted to enable parties, either states or individuals, to seek compensation with regard to contamination...